Tyrosine Kinase Inhibitors Gefitinib, Lapatinib and Sorafenib Induce Rapid Functional Alterations in Breast Cancer Cells

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 422-431

Bentham Science Publishers

Access to resources Recommend Favorite

Selective tyrosine kinase inhibitors

By Wilkinson S.E.   Harris W.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 462-483

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular toxicity of tyrosine kinase inhibitors

By Mouhayar Elie   Durand Jean-Bernard   Cortes Jorge  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

By Jeha Sima   Coustan-Smith Elaine   Pei Deqing   Sandlund John T.   Rubnitz Jeffrey E.   Howard Scott C.   Inaba Hiroto   Bhojwani Deepa   Metzger Monika L.   Cheng Cheng   Choi John K.   Jacobsen Jeffrey   Shurtleff Sheila A.   Raimondi Susana   Ribeiro Raul C.   Pui Ching-Hon   Campana Dario  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1514-1519

Blackwell Publishing

Access to resources Recommend Favorite